Atlas Trials

Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

Clinical trial NCT07197788 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07197788
Sponsor
Endogenex, Inc.
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusType2diabetesDiabetes Mellitus, Type 2Type 2 DiabetesDiabetes
Start date
2026-09-01
Primary completion
2027-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.